Patent · US Active

MTOR inhibitor compounds

US11518767B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2020
Grant dateDec 6, 2022
Priority date
Expiry dateJun 19, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to novel mTOR inhibitor compounds having the general formula (I), to compositions comprising said mTOR inhibitor compounds, methods for producing same, and the use thereof in compositions as a drug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.